PE20221446A1 - Nuevas formulaciones de comprimido de fosfomicina - Google Patents

Nuevas formulaciones de comprimido de fosfomicina

Info

Publication number
PE20221446A1
PE20221446A1 PE2022000222A PE2022000222A PE20221446A1 PE 20221446 A1 PE20221446 A1 PE 20221446A1 PE 2022000222 A PE2022000222 A PE 2022000222A PE 2022000222 A PE2022000222 A PE 2022000222A PE 20221446 A1 PE20221446 A1 PE 20221446A1
Authority
PE
Peru
Prior art keywords
tablet
composition
anhydrous
fosfomicin
new formulations
Prior art date
Application number
PE2022000222A
Other languages
English (en)
Inventor
Ortega Marta Prior
Olle Ramon Francesch
Original Assignee
Labiana Health S L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Labiana Health S L filed Critical Labiana Health S L
Publication of PE20221446A1 publication Critical patent/PE20221446A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Abstract

Referido a una composicion farmaceutica oral en forma de comprimido que comprende: fosfomicina trometamol, hidrogenofosfato de calcio anhidro, celulosa microcristalina anhidra, opcionalmente un lubricante y otros excipientes. En donde dicha composicion comprende: desde el 80% hasta el 95% p/p de fosfomicina trometamol, desde 5% hasta 20% p/p de una combinacion de hidrogenofosfato de calcio anhidro y celulosa microcristalina anhidra, opcionalmente, desde 0,1 % hasta 3% p/p de lubricante; y otros excipientes farmaceuticamente aceptables en una cantidad suficiente para completar el 100% del peso total de la composicion. Tambien se refiere a un metodo para fabricar la composicion del comprimido y su uso como medicamento veterinario.
PE2022000222A 2021-02-10 2022-02-09 Nuevas formulaciones de comprimido de fosfomicina PE20221446A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP21382104 2021-02-10

Publications (1)

Publication Number Publication Date
PE20221446A1 true PE20221446A1 (es) 2022-09-21

Family

ID=74732835

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2022000222A PE20221446A1 (es) 2021-02-10 2022-02-09 Nuevas formulaciones de comprimido de fosfomicina

Country Status (10)

Country Link
US (1) US11833250B2 (es)
EP (1) EP4043006B1 (es)
AR (1) AR124833A1 (es)
BR (1) BR102022002475A2 (es)
CA (1) CA3147662A1 (es)
CO (1) CO2022001244A1 (es)
CU (1) CU20220009A7 (es)
MX (1) MX2022001746A (es)
PE (1) PE20221446A1 (es)
TW (1) TW202245740A (es)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20021725A1 (it) 2002-08-01 2002-10-31 Zambon Spa Composizioni farmaceutiche ad attivita' antibiotica.
ES2244333B1 (es) 2004-05-18 2006-08-01 Simbec Iberica, Sl Preparado farmaceutico oral de fosfomicina estable y apto para diabeticos.
TW201129386A (en) 2009-11-05 2011-09-01 Fmc Corp Microcrystalline cellulose and calcium phosphate compositions useful as pharmaceutical excipients
ES2385158B1 (es) 2010-12-24 2013-05-28 Arafarma Group, S.A. Composición farmacéutica de fosfomicina
US8604078B2 (en) 2011-04-06 2013-12-10 Carlos Picornell Darder Fosfomycin pharmaceutical composition

Also Published As

Publication number Publication date
TW202245740A (zh) 2022-12-01
EP4043006C0 (en) 2023-12-06
BR102022002475A2 (pt) 2022-08-23
CA3147662A1 (en) 2022-08-10
CO2022001244A1 (es) 2023-02-16
US11833250B2 (en) 2023-12-05
MX2022001746A (es) 2022-08-11
AR124833A1 (es) 2023-05-10
EP4043006A1 (en) 2022-08-17
EP4043006B1 (en) 2023-12-06
US20220387329A1 (en) 2022-12-08
CU20220009A7 (es) 2023-09-07

Similar Documents

Publication Publication Date Title
CL2019000209A1 (es) Formulación novedosa administrable por la vía oral.
CO6400186A2 (es) Tabletas de acetato de ulipristal
CY1116698T1 (el) Συνθεση περιεχοντας υπερ-μικρονοποιημενο παλμιτοϋλ-αιθανολαμιδιο
UY30537A1 (es) Formulaciones de flibanserina y metodo para fabricarlas
EA201690102A1 (ru) Фармацевтическая композиция, содержащая диметилфумарат, для введения в низкой суточной дозе
AR069312A1 (es) Composicion farmaceutica que comprende beta oxihidroxido de hierro en alta carga en forma adecuada para administarcion oral y que contiene al menos un hidrato de carbono y/o acido humico y su uso en el tratamiento de pacientes con hiperfosfatemia y con insuficiencia renal cronica , y procedimento pa
AR066420A1 (es) Composicion farmaceutica suministrable oronasofaringeamente para la prevencion alivio / y o tratamiento de trastornos de miembros inquietos. uso.
SG158870A1 (en) Bendamustine pharmaceutical compositions for lyophilisation
CL2016001411A1 (es) Unidad de dosificación farmacéutica solida de desintegración oral que comprende un componente de estetrol; metodo de preparación; uso para la anticoncepción femenina y en terápia de sustitución hormonal femenina.
AR107391A1 (es) Formulaciones / composiciones que comprenden un inhibidor de btk
AR081774A1 (es) Composiciones farmaceuticas de co-cristales de tramadol y coxibs
AR062167A1 (es) Sistema de administracion gastrorretentivo
UA116334C2 (uk) Тверді форми дозування бендамустину
AR084102A1 (es) Comprimido farmaceutico que comprende el solvato de dimetilsulfoxido de la n-{3-[3-ciclopropil-5-(2-fluoro-4-yodo-fenilamino)-6,8-dimetil-2,4,7-trioxo-3,4,6,7-tetrahidro-2h-pirido[4,3-d]pirimidin-1-il]fenil}acetamida, su uso para preparar un medicamento util para tratar el cancer en un ser humano y procedimiento para preparar dichos comprimidos
PH12021550218A1 (en) Use of riluzole oral disintigrating tablets for treating diseases
PH12020551911A1 (en) Use of riluzole oral disintigrating tablets for treating diseases
AR065816A1 (es) Regimen anticonceptivo oral
PE20221446A1 (es) Nuevas formulaciones de comprimido de fosfomicina
PE20142460A1 (es) Composiciones farmaceuticas orales estables de liberacion inmediata que contienen prasugrel
RS54721B1 (en) PHARMACEUTICAL AEROSOL FORMOTEROL FORMULATION AND BECLOMETHASONE DIPROPIONATE
AR048970A1 (es) Formulacion farmaceutica solida
AR093252A1 (es) Composicion farmaceutica oral utilizada como antiparasitaria y antidiarreica y procesos para prepararla
MX2015015681A (es) Composicion farmaceutica que comprende fingolimod.
MY191983A (en) Pharmaceutical formulations comprising sodium palmitoyl-l-prolyl-l-prolyl-glycyl-l-tyrosinate and methods for preparing the same
PE20230105A1 (es) Forma de dosificacion que proporciona liberacion prolongada de sal de acido fosforico de tapentadol